International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers

Journal of Magnetic Resonance Imaging

Volumn 32, Issue 2, 2010, Pages 315-319

  Kirk, Paul ^a   He, Taigang ^a   Anderson, Lisa J ^a   Roughton, Michael ^a   Tanner, Mark A ^a   Lam, Wynnie W M ^b   Au, Wing Y ^c   Chu, Winnie C W ^b   Chan, Godfrey ^c   Galanello, Renzo ^d   Matta, Gildo ^e   Fogel, Mark ^f   Cohen, Alan R ^f   Tan, Ru San ^g   Chen, Kevin ^h   Ng, Ivy ⁱ   Lai, Angie ⁱ   Fucharoen, Suthat ^j   Laothamata, Jiraporn ^k   Chuncharunee, Suporn ^k   Jongjirasiri, Sutipong ^k   Firmin, David N ^a   Smith, Gillian C ^a   Pennell, Dudley J ^a   more..

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d Osp Regionale per le Microcitemie   (Italy)

^e BROTZU HOSPITAL   (Italy)

^f CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^g DEPARTMENT OF CARDIOLOGY   (Singapore)

^h SINGAPORE GENERAL HOSPITAL   (Singapore)

ⁱ KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^j MAHIDOL UNIVERSITY   (Thailand)

^k MAHIDOL UNIVERSITY   (Thailand)

more..

Author keywords

Cardiac siderosis; Cardiomyopathy; Cardiovascular MR; Thalassemia

Indexed keywords

CARDIOVASCULAR AGENT; DEFERASIROX; DEFERIPRONE; DEFEROXAMINE; FERRITIN; IRON;

ADULT; ARTICLE; BLOOD TRANSFUSION; BREATH HOLDING; CARDIOMYOPATHY; CHELATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DIAGNOSTIC IMAGING; FEMALE; FERRITIN BLOOD LEVEL; HEART; HUMAN; IRON OVERLOAD; LIVER; LIVER DISEASE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; REPRODUCIBILITY; SIDEROSIS; THALASSEMIA; THALASSEMIA MAJOR; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

ADULT; FEMALE; HUMANS; IRON; IRON OVERLOAD; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIUM; OBSERVER VARIATION; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; THALASSEMIA;

EID: 77955365667     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22245     Document Type: Article

References (19)

1. Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004;89:1187-1193.
2. Anderson LJ, Westwood MA, Holden S, et al. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol 2004;127:348-355.
3. Porter JB. Practical management of iron overload. Br J Haematol 2001;115:239-252.
4. Jessup M, Manno CS. Diagnosis and management of iron-induced heart disease in Cooley's anemia. Ann N Y Acad Sci 1998;850:242-250. (Pubitemid 28369765)
5. Tanner MA, Galanello R, Dessi C, et al. Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. J Cardiovasc Magn Reson 2006;8:543-547.
6. Walker JM. The heart in thalassaemia. Eur Heart J 2002;23:102-105.
7. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-2179.
8. Westwood MA, Firmin DN, Gildo M, et al. Intercentre reproducibility of magnetic resonance T2* measurements of myocardial iron in thalassaemia. Int J Cardiovasc Imaging 2005;21:531-538.
9. Tanner MA, He T, Westwood MA, Firmin DN, Pennell DJ. Multicenter validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron. Haematologica 2006;91:1388-1391. (Pubitemid 44569814)
10. Argyropoulou MI, Astrakas L. MRI evaluation of tissue iron burden in patients with beta-thalassaemia major. Pediatr Radiol 2007;37:1191-1200.
11. Wood JC. Magnetic resonance imaging measurement of iron over-load. Curr Opin Hematol 2007;14:183-190. (Pubitemid 46597601)
12. Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2008;10:42.
13. Tanner MA, Galanello R, Dessi C, et al. Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction. J Cardiovasc Magn Reson 2008;10:12.
14. Westwood M, Anderson LJ, Firmin DN, et al. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 2003;18:33-39.
15. He T, Gatehouse PD, Smith GC, Mohiaddin RH, Pennell DJ, Firmin DN. Myocardial T2* measurements in iron-overloaded thalassemia: an in vivo study to investigate optimal methods of quantification. Magn Reson Med 2008;60:1082-1089.
16. Wood JC, Otto-Duessel M, Aguilar M, et al. Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy. Circulation 2005;112:535-543.
17. Kirk P, Roughton M, Porter JB, et al. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation 2009;120:1961-1968.
18. Pennell DJ, Berdoukas V, Karagiorga M, et al. Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. Blood 2006;107:3738-3744.
19. Tanner MA, Galanello R, Dessi C, et al. A randomized, placebocontrolled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation 2007;115:1876-1884.